After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut ...

The first-of-its-kind facility in India has received an investment of $75 million from the company to build it vertically ...

Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...

Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...

Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...

The Moderna, Pfizer-BioNTech, and Novavax vaccines protect against many known variants of COVID-19. The Moderna and Pfizer-BioNTech vaccines offer immunity against COVID-19 for up to six months. To ...

Immunotherapy company Nouscom is developing engineered viral vector vaccines against cancer. The Swiss-Italian startup has two vaccine candidates in its pipeline, namely, NOUS-209 and NOUS-PEV. Phase ...

McMaster University has developed an inhaled COVID-19 vaccine and studies are starting phase-two of human trials.

With the virus spreading rapidly around the world, the need for a vaccine was desperate — but the prior record for the fastest development of a new vaccine to a new virus was four years.

the vaccine developed by WashU Medicine uses an adenovirus vector to deliver its payload. Adenoviruses are DNA viruses that have easily modifiable genomes. Scientists can deactivate the genes in ...

The current measles outbreak might make you wonder whether you need a booster vaccine. If you’re fully vaccinated—meaning you have received two doses of the MMR (measles-mumps-rubella) vaccine—you ...